Results 191 to 200 of about 101,700 (245)

Real-World Outcomes With Low-Dose Dasatinib (50 mg) in Imatinib-Resistant Chronic Myeloid Leukemia in Chronic Phase: A Retrospective Analysis of Efficacy and Safety. [PDF]

Cancer Rep (Hoboken)
Gangadaran N, Mamlekar H, Saha S, Kashyap R, Yadav S, Rahman K, Gupta R, Vijayaran M, Singh M, Chandra D.   +9 more
europepmc   +1 more source

Transanal endoscopic microsurgery (TEM) for rectal GI stromal tumour. [PDF]

Surg Endosc
Arezzo A, Distefano G, Ammirati CA, Barbiero M, Arolfo S, Morino M.   +5 more
europepmc   +1 more source

15-year ultra-late presentation of bifocal hepatic metastasis from gastrointestinal stromal tumor: a case report. [PDF]

Front Surg
Hou Y, Zhong S, Chen H, Cao F, Xu A.
europepmc   +1 more source

Case Report: Co-existence of <i>BCR::PDGFRA</i> gene fusion and <i>PDGFRA</i> variants in myeloid neoplasm with persistent leukocytosis, large splenomegaly, and eosinophilia. [PDF]

Front Oncol
Xiao Z, Lu C, Zhang P, Han N, He X, Zhang J, Feng Y, Guan M, Ouyang L, Gao Y, Li Y.   +10 more
europepmc   +1 more source

Asciminib and pulsed ATRA as post-remission therapy in T315I mutated PML-RARA-positive blast crisis of chronic myeloid leukemia. [PDF]

Ann Hematol
Mazzarella R, Cicconi L, Perrone S, Divona MD, Ceccolini S, Nardozza AM, Biagi A, Ottone T, Corbingi A, Panetta P, La Barbera EO, Fiori L, Romeo AA, Pacitto G, Cotroneo E, Breccia M, Voso MT, Pulsoni A.   +17 more
europepmc   +1 more source

Clinical utility of comprehensive genomic profiling in 175 Japanese patients with advanced skin malignancies refractory to standard therapies. [PDF]

JAAD Int
Kambayashi Y, Fujimura T, Kato H, Kado S, Maekawa T, Ono F, Ito T, Aoki M, Matsushita S, Miyashita A, Fukushima S, Rokunohe D, Yamazaki E, Takahashi-Watanabe M, Asano M, Asano Y.   +15 more
europepmc   +1 more source

The Successful Treatment of Primary and Recurrent Ruptured Gastric Gastrointestinal Stromal Tumor (GIST) Through Coordinated Surgical Intervention and c-Kit Inhibitor Therapy. [PDF]

Cureus
Hirayama S, Kawashita Y, Tateishi M, Ueda T, Yamaguchi J, Haraguchi M, Umeda K, Nakamura M, Abe S, Harada S, Washida Y, Hachitanda Y.   +11 more
europepmc   +1 more source

Genetic Variations in the M6A Modification Pathway as Potential Predictors of Imatinib Secondary Resistance in Gastrointestinal Stromal Tumors. [PDF]

J Clin Med
Zhou B, Chen Z, Zhang G, Guan S, Zhuang W, Huang M, Qiu H, Wang X.   +7 more
europepmc   +1 more source

Hypoxic conditions confer chemoresistance to crizotinib but not to imatinib in chronic myeloid leukemia cells. [PDF]

Hematol Transfus Cell Ther
Avinery L, Regev D, Khamaisi H, Gopas J, Mahajna J.   +4 more
europepmc   +1 more source

Biological Features of KLC2 Mutations in Chronic Myeloid Leukemia and Their Contribution to Inducing Drug Resistance. [PDF]

Oncol Res
Bera R, Ochi Y, Huang YJ, Kuo MC, Yoshida K, Ogawa S, Shih LY.   +6 more
europepmc   +1 more source